Trichinella pseudospiralis infection is characterized by more continuous and diffuse myopathy than T. spiralis

T Boonmars1, Z Wu, I Nagano

  • 1Department of Parasitology, Gifu University School of Medicine, Yanagido1-1, Gifu 501-1194, Japan.

Parasitology Research
|June 11, 2005
PubMed

Insights

Trichinella pseudospiralis infection causes diffuse myopathy and delayed muscle cell disintegration in mice compared to Trichinella spiralis. This is linked to prolonged expression of apoptosis-related genes in infected muscle tissue.

Area of Science:

  • Parasitology
  • Immunology
  • Molecular Biology

Background:

  • Trichinella spiralis and T. pseudospiralis are parasitic nematodes causing trichinellosis.
  • Histopathological differences in muscle infection by these species are not fully understood.

Purpose of the Study:

  • To compare the histopathology and molecular responses to Trichinella spiralis and T. pseudospiralis infections in mice.
  • To elucidate the role of apoptosis-related gene expression in the myopathy caused by these parasites.

Main Methods:

  • Time-course histopathology and electron microscopy in infected mice.
  • Quantitative reverse transcription polymerase chain reaction (RT-PCR) to analyze apoptosis-related gene expression.
  • Micro-dissection of infected muscle tissue for targeted gene expression analysis.

Main Results:

  • T. spiralis infection formed cysts with localized myopathy, while T. pseudospiralis caused diffuse myopathy without cyst formation.
  • Muscle cell disintegration was delayed in T. pseudospiralis infections.
  • Apoptosis-related genes (p53, MDM2, p21, BAX, Apaf-1, Caspase 9, PKB) showed prolonged expression in T. pseudospiralis-infected muscles, correlating with myopathy extent.

Conclusions:

  • T. pseudospiralis induces a more severe and widespread myopathy than T. spiralis.
  • Prolonged apoptosis-related gene expression is a key feature of T. pseudospiralis-induced myopathy.

Related Concept Videos

Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...